Psychiatric disturbances regulate the innate immune system in CSF of conscious mice

Translational Psychiatry

Volumn 4, Issue 3, 2014, Pages

  Onaivi, E S ^a   Schanz, N ^a   Lin, Z C ^b,c  

^a WILLIAM PATERSON UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MCLEAN HOSPITAL   (United States)

Author keywords

Addiction; Cocaine; Signaling pathways; Stress

Indexed keywords

COCAINE; PROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DISEASE; BRAIN FUNCTION; C57BL 6 MOUSE; CEREBROSPINAL FLUID; CONSCIOUSNESS; DISEASE ASSOCIATION; DOWN REGULATION; INNATE IMMUNITY; MALE; MASS SPECTROMETRY; MENTAL DISEASE; MOUSE; NEUROIMMUNOLOGY; NONHUMAN; SCHIZOPHRENIA; STRESS; UPREGULATION; ANIMAL; BRAIN; C57BL MOUSE; DISEASE MODEL; IMMUNOLOGY; MENTAL STRESS; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN; CEREBROSPINAL FLUID; COCAINE; DISEASE MODELS, ANIMAL; IMMUNITY, INNATE; MALE; MENTAL DISORDERS; MICE; MICE, INBRED C57BL; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL;

EID: 84903889880     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2014.5     Document Type: Article

References (49)

1. Gold PW, Licinio J, Pavlatou MG. Pathological parainflammation and endoplasmic reticulum stress in depression: potential translational targets through the CNS insulin, klotho and PPAR-? systems. Mol Psychiatry 2013; 18: 154-165.
2. Wei L, Simen A, Mane S, Kaffman A. Early life stress inhibits expression of a novel innate immune pathway in the developing hippocampus. Neuropsychopharmacology 2012; 37: 567-580.
3. Terrando N, Eriksson LI, Ryu JK, Yang T, Monaco C, Feldmann M et al. Resolving postoperative neuroinflammation and cognitive decline. Ann Neurol 2011; 70: 986-995.
4. Raison CL, Rye DB, Woolwine BJ, Vogt GJ, Bautista BM, Spivey JR et al. Chronic interferon-alpha administration disrupts sleep continuity and depth in patients with hepatitis C: association with fatigue, motor slowing, and increased evening cortisol. Biol Psychiatry 2010; 68: 942-949.
5. Boulanger LM. Immune proteins in brain development and synaptic plasticity. Neuron 2009; 64: 93-109.
6. Schafer DP, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR, Yamasaki R et al. Microglia sculpt postnatal neural circuits in an activity and complementdependent manner. Neuron 2012; 74: 691-705.
7. Di Filippo M, Chiasserini D, Gardoni F, Viviani B, Tozzi A, Giampà C et al. Effects of central and peripheral inflammation on hippocampal synaptic plasticity. Neurobiol Dis 2013; 52: 229-236.
8. Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 2012; 367: 795-804.
9. Papadopoulos MC, Verkman AS. Aquaporin water channels in the nervous system. Nat Rev Neurosci 2013; 14: 265-277.
10. Höftberger R, Sabater L, Ortega A, Dalmau J, Graus F. Patient with homer-3 antibodies and cerebellitis. JAMA Neurol 2013; 70: 506-509.
11. Parnetti L, Castrioto A, Chiasserini D, Persichetti E, Tambasco N, El-Agnaf O et al. Cerebrospinal fluid biomarkers in Parkinson disease. Nat Rev Neurol 2013; 9: 131-140.
12. Luykx JJ, Bakker SC, Lentjes E, Neeleman M, Strengman E, Mentink Let al. Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid. Mol Psychiatry 2014; 19: 228-234.
13. Stephan AH, Barres BA, Stevens B. The complement system: an unexpected role in synaptic pruning during development and disease. Annu Rev Neurosci 2012; 35: 369-389.
14. Cramer PE, Cirrito JR, Wesson DW, Lee CY, Karlo JC, Zinn AE et al. ApoE-directed therapeutics rapidly clear?-amyloid and reverse deficits in AD mouse models. Science 2012; 335: 1503-1506.
15. Han S, Tai C, Westenbroek RE, Yu FH, Cheah CS, Potter GB et al. Autistic-like behaviour in Scn1a+/? mice and rescue by enhanced GABA-mediated neurotransmission. Nature 2012; 489: 385-390.
16. Giovanoli S, Engler H, Engler A, Richetto J, Voget M, Willi R et al. Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice. Science 2013; 339: 1095-1099.
17. Niwa M, Jaaro-Peled H, Tankou S, Seshadri S, Hikida T, Matsumoto Y et al. Adolescent stress-induced epigenetic control of dopaminergic neurons via glucocorticoids. Science 2013; 339: 335-339.
18. Chaudhury D, Walsh JJ, Friedman AK, Juarez B, Ku SM, Koo JW et al. Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons. Nature 2013; 493: 532-536.
19. Vom Berg J, Prokop S, Miller KR, Obst J, Kälin RE, Lopategui-Cabezas I et al. Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline. Nat Med 2012; 18: 1812-1819.
20. Kallupi M, Cannella N, Economidou D, Ubaldi M, Ruggeri B, Weiss F et al. Neuropeptide S facilitates cue-induced relapse to cocaine seeking through activation of the hypothalamic hypocretin system. Proc Natl Acad Sci USA 2010; 107: 19567-19572.
21. DeMattos RB, Bales KR, Parsadanian M, O'Dell MA, Foss EM, Paul SM et al. Plaqueassociated disruption of CSF and plasma amyloid-beta (Abeta) equilibrium in a mouse model of Alzheimer's disease. J Neurochem 2002; 81: 229-236.
22. Second TP, Blethrow JD, Schwartz JC, Merrihew GE, MacCoss MJ, Swaney DL et al. Dual-pressure linear ion trap mass spectrometer improving the analysis of complex protein mixtures. Anal Chem 2009; 81: 7757-7765.
23. Yang X, Dondeti V, Dezube R, Maynard DM, Geer LY, Epstein J. et al. DBParser: web-based software for shotgun proteomic data analyses. J Proteome Res 2004; 3: 1002-1008.
24. Ekins S, Nikolsky Y, Bugrim A, Kirillov E, Nikolskaya T. Pathway mapping tools for analysis of high content data. Methods Mol Biol 2007; 356: 319-350.
25. Moylan S, Maes M, Wray NR, Berk M. The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol Psychiatry 2013; 18: 595-606.
26. Balu DT, Li Y, Puhl MD, Benneyworth MA, Basu AC, Takagi S et al. Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction. Proc Natl Acad Sci USA 2013; 110: E2400-E2409.
27. Rahrmann EP, Watson AL, Keng VW, Choi K, Moriarity BS, Beckmann DA et al. Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. Nat Genet 2013; 45: 756-766.
28. Kim SY, Adhikari A, Lee SY, Marshel JH, Kim CK, Mallory CS et al. Diverging neural pathways assemble a behavioural state from separable features in anxiety. Nature 2013; 496: 219-223.
29. Cui G, Jun SB, Jin X, Pham MD, Vogel SS, Lovinger DM et al. Concurrent activation of striatal direct and indirect pathways during action initiation. Nature 2013; 494: 238-242.
30. Baxt LA, Garza-Mayers AC, Goldberg MB. Bacterial subversion of host innate immune pathways. Science 2013; 340: 697-701.
31. Lu MS, Johnston CA. Molecular pathways regulating mitotic spindle orientation in animal cells. Development 2013; 140: 1843-1856.
32. Braunschweig U, Gueroussov S, Plocik AM, Graveley BR, Blencowe BJ. Dynamic integration of splicing within gene regulatory pathways. Cell 2013; 152: 1252-1269.
33. Williams FM, Carter AM, Hysi PG, Surdulescu G, Hodgkiss D, Soranzo N et al. Ischemic stroke is associated with the ABO locus: the EuroCLOT study. Ann Neurol 2013; 73: 16-31.
34. Jickling GC, Ander BP, Stamova B, Zhan X, Liu D, Rothstein Let al. RNA in blood is altered prior to hemorrhagic transformation in ischemic stroke. Ann Neurol 2013.: doi: 10.1002/ana.23883; e-pub ahead of print.
35. Sashindranath M, Sales E, Daglas M, Freeman R, Samson AL, Cops EJ et al. The tissue-type plasminogen activator-plasminogen activator inhibitor 1 complex promotes neurovascular injury in brain trauma: evidence from mice and humans. Brain 2012; 135: 3251-3264.
36. Vandenbroucke RE, Dejonckheere E, Van Lint P, Demeestere D, Van Wonterghem E, Vanlaere I et al. Matrix metalloprotease 8-dependent extracellular matrix cleavage at the blood-CSF barrier contributes to lethality during systemic inflammatory diseases. J Neurosci 2012; 32: 9805-9816.
37. Berg A, Zelano J, Thams S, Cullheim S. The extent of synaptic stripping of motoneurons after axotomy is not correlated to activation of surrounding glia or downregulation of postsynaptic adhesion molecules. PLoS One 2013; 8: e59647.
38. Arion D, Unger T, Lewis DA, Levitt P, Mirnics K. Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatry 2007; 62: 711-721.
39. Fillman SG, Cloonan N, Catts VS, Miller LC, Wong J, McCrossin T et al. Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol Psychiatry 2013; 18: 206-214.
40. Vawter MP, Ferran E, Galke B, Cooper K, Bunney WE, Byerley W. Microarray screening of lymphocyte gene expression differences in a multiplex schizophrenia pedigree. Schizophr Res 2004; 67: 41-52.
41. Vawter MP, Shannon Weickert C, Ferran E, Matsumoto M, Overman K, Hyde TM et al. Gene expression of metabolic enzymes and a protease inhibitor in the prefrontal cortex are decreased in schizophrenia. Neurochem Res 2004; 29: 1245-1255.
42. Christian CA, Herbert AG, Holt RL, Peng K, Sherwood KD, Pangratz-Fuehrer S et al. Endogenous positive allosteric modulation of GABA(A) receptors by diazepam binding inhibitor. Neuron 2013; 78: 1063-1074.
43. Regenold WT, Phatak P, Marano CM, Sassan A, Conley RR, Kling MA. Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis. Biol Psychiatry 2009; 65: 489-494.
44. Rothermundt M, Falkai P, Ponath G, Abel S, Bürkle H, Diedrich M et al. Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF. Mol Psychiatry 2004; 9: 897-899.
45. Thompson PM, Kelley M, Yao J, Tsai G, van Kammen DP. Elevated cerebrospinal fluid SNAP-25 in schizophrenia. Biol Psychiatry 2003; 53: 1132-1137.
46. Raison CL, Dantzer R, Kelley KW, Lawson MA, Woolwine BJ, Vogt G et al. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol Psychiatry 2010; 15: 393-403.
47. Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 2013; 200: 373-383.
48. Lee Y, El Andaloussi S, Wood MJ. Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum Mol Genet 2012; 21: R125-R134.
49. Belting M, Wittrup A. Nanotubes, exosomes, and nucleic acid-binding peptides provide novel mechanisms of intercellular communication in eukaryotic cells: implications in health and disease. J Cell Biol 2008; 183: 1187-1191.